Imperial College London
London, United Kingdom
Purpose
to evaluate the potential efficacy of a Ribonucleic acid (RNA) vaccine against COVID-19
Division
Global Health
Date
July 2020
Region Served
GLOBAL
Committed amount
$1,080,771
Grant topic
Discovery and Translational Sciences
Duration (months)
51
Grantee location
London, United Kingdom
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.